Mimedx (MDXG) Net Shares Issued and Repurchased (2014 - 2017)
Mimedx (MDXG) reported Net Shares Issued and Repurchased of -$24.2 million for Q4 2017, up 17.27% sequentially from -$29.3 million in Q3 2017.
Mimedx (MDXG) Net Shares Issued and Repurchased (2014 - 2017) Analysis & Trends
Mimedx (MDXG) has 4 years of Net Shares Issued and Repurchased data on file, last reported at -$24.2 million in Q4 2017.
- For the quarter ending Q4 2017, Net Shares Issued and Repurchased changed N/A year-over-year to -$24.2 million; the trailing twelve-month figure through Dec 2017 stood at -$68.3 million (down 557.77% YoY), and the FY2018 full-year result was -$7.6 million, up 88.91% from the prior year.
- Net Shares Issued and Repurchased climbed to -$24.2 million in Q4 2017, from -$29.3 million in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of -$300000.0 in Q4 2014 to a low of -$29.3 million in Q3 2017.
- A 4-year average of -$9.6 million and a median of -$4.6 million in 2014 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased sank 6303.67% in 2015 and soared 71.29% in 2016, its largest moves.
- Tracing MDXG's Net Shares Issued and Repurchased over 4 years: stood at -$300000.0 in 2014, then plunged by 6303.67% to -$19.2 million in 2015, then jumped by 64.35% to -$6.8 million in 2016, then plunged by 253.84% to -$24.2 million in 2017.
- Business Quant data shows MDXG's Net Shares Issued and Repurchased at -$24.2 million in Q4 2017, -$29.3 million in Q3 2017, and -$2.1 million in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | - |
| 10 | Mimedx | 646.48 Mn | 486.71 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -24.23 Mn |
| Dec 31, 2017 | -24.23 Mn |
| Sep 30, 2017 | -29.29 Mn |
| Sep 30, 2017 | -29.29 Mn |
| Jun 30, 2017 | -2.08 Mn |
| Jun 30, 2017 | -2.08 Mn |
| Mar 31, 2017 | -12.67 Mn |
| Mar 31, 2017 | -12.67 Mn |
| Sep 30, 2016 | -6.85 Mn |
| Sep 30, 2016 | -6.85 Mn |
| Mar 31, 2016 | -3.53 Mn |
| Mar 31, 2016 | -3.53 Mn |
| Dec 31, 2015 | -19.21 Mn |
| Dec 31, 2015 | -19.21 Mn |
| Sep 30, 2015 | -4.43 Mn |
| Sep 30, 2015 | -4.43 Mn |
| Jun 30, 2015 | -4.35 Mn |
| Jun 30, 2015 | -4.35 Mn |
| Mar 31, 2015 | -12.30 Mn |
| Mar 31, 2015 | -12.30 Mn |